A detailed history of Holocene Advisors, LP transactions in Boston Scientific Corp stock. As of the latest transaction made, Holocene Advisors, LP holds 3,997,632 shares of BSX stock, worth $360 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares
3,997,632
Previous 4,040,430 1.06%
Holding current value
$360 Million
Previous $311 Million 7.66%
% of portfolio
1.46%
Previous 1.38%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$72.96 - $84.0 $3.12 Million - $3.6 Million
-42,798 Reduced 1.06%
3,997,632 $335 Million
Q2 2024

Aug 14, 2024

SELL
$67.33 - $77.71 $118 Million - $136 Million
-1,747,569 Reduced 30.19%
4,040,430 $311 Million
Q1 2024

May 15, 2024

SELL
$57.6 - $68.62 $121 Million - $144 Million
-2,097,160 Reduced 26.6%
5,787,999 $396 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $44.2 Million - $52.5 Million
908,423 Added 13.02%
7,885,159 $456 Million
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $45.4 Million - $49.5 Million
904,969 Added 14.9%
6,976,736 $368 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $85.4 Million - $93.8 Million
1,717,569 Added 39.45%
6,071,767 $328 Million
Q1 2023

May 15, 2023

BUY
$45.09 - $50.03 $196 Million - $218 Million
4,354,198 New
4,354,198 $218 Million
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $6.71 Million - $20 Million
-182,781 Reduced 5.1%
3,398,887 $132 Million
Q2 2022

Aug 15, 2022

SELL
$35.24 - $47.1 $11.2 Million - $15 Million
-318,482 Reduced 8.17%
3,581,668 $133 Million
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $25.3 Million - $27.9 Million
619,103 Added 18.87%
3,900,150 $173 Million
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $21.4 Million - $25.2 Million
560,862 Added 20.62%
3,281,047 $139 Million
Q3 2021

Nov 15, 2021

BUY
$41.23 - $45.88 $3.21 Million - $3.57 Million
77,740 Added 2.94%
2,720,185 $118 Million
Q2 2021

Aug 16, 2021

SELL
$38.58 - $44.24 $89.9 Million - $103 Million
-2,329,494 Reduced 46.85%
2,642,445 $113 Million
Q1 2021

May 17, 2021

BUY
$35.27 - $39.67 $157 Million - $177 Million
4,454,432 Added 860.75%
4,971,939 $192 Million
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $54.7 Million - $69.3 Million
-1,650,239 Reduced 76.13%
517,507 $18.6 Million
Q3 2020

Nov 16, 2020

BUY
$34.44 - $42.23 $74.7 Million - $91.5 Million
2,167,746 New
2,167,746 $82.8 Million
Q4 2019

Feb 14, 2020

SELL
$37.87 - $45.37 $23.6 Million - $28.3 Million
-623,762 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$40.31 - $43.45 $5.36 Million - $5.78 Million
-133,079 Reduced 17.58%
623,762 $25.4 Million
Q2 2019

Aug 14, 2019

BUY
$34.91 - $42.98 $26.4 Million - $32.5 Million
756,841 New
756,841 $32.5 Million
Q2 2018

Aug 14, 2018

SELL
$26.84 - $34.32 $563,264 - $720,239
-20,986 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$25.2 - $28.54 $25,174 - $28,511
999 Added 5.0%
20,986 $573,000
Q4 2017

Feb 14, 2018

BUY
$24.79 - $29.8 $495,477 - $595,612
19,987
19,987 $495,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.